EX-99.C 3 d477521dex99c.htm EX-99.C EX-99.C

Exhibit C

Joint Filing Statement

I, the undersigned, hereby express my agreement that the attached Schedule 13D (and any amendments thereto) relating to the beneficial ownership by the undersigned of the equity securities of Rhythm Pharmaceuticals, Inc. is filed on behalf of each of the undersigned.

Date: October 24, 2017

 

MPM BIOVENTURES V GP LLC
By:   MPM BioVentures V LLC,
  its Managing Member
By:  

/s/ Todd Foley

Name:   Todd Foley
Title:   Member
MPM BIOVENTURES V LLC
By:  

/s/ Todd Foley

Name:   Todd Foley
Title:   Member
MPM BIOVENTURES V, L.P.
By:   MPM BioVentures V GP LLC, its General Partner
By:   MPM BioVentures V LLC, its Managing Member
By:  

/s/ Todd Foley

Name:   Todd Foley
Title:   Member
MPM ASSET MANAGEMENT INVESTORS BV5 LLC
By:   MPM BioVentures V LLC
  Its: Manager
By:  

/s/ Todd Foley

Name:   Todd Foley
Title:   Member
By:  

/s/ Todd Foley

Name:   Todd Foley
By:  

/s/ Luke Evnin

Name:   Luke Evnin
By:  

/s/ Ansbert Gadicke

Name:   Ansbert Gadicke

 

Page 19